The Lancet Oncology· Stefanie Weigel, Hans-Werner Hense, Veronika Weyer-Elberich, Jörg Czwoydzinski, Thomas Decker, Hiltraud Kajüter, Florian Oesterling, Jasper Heilmann, Andreas Stang, Joachim Kieschke, Susanne Wienbeck, Oliver Stephan, Sonja Baier, Miriam Krischke, Alexander Sommer, Joachim Gerß, Walter Heindel, TOSYMA Screening Trial Study Group·· 2026-10-10AI 评分40
TOSYMA-2试验:数字乳腺断层扫描联合合成mammography与数字mammography筛查对侵袭性间隔乳腺癌率的影响(24个月随访)
[Articles] Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial
AI 导读
TOSYMA-2试验显示,数字乳腺断层扫描联合合成mammography筛查可能减少约四分之一的侵袭性间隔乳腺癌发生率(24个月随访)。该多中心、开放标签、随机对照试验主要终点未达统计学显著,但提供了重要证据支持新型筛查方案的潜在价值。研究结果或为优化乳腺癌筛查策略提供参考依据。
来源:The Lancet Oncology · thelancet.com